Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 18, 2019

View Archived Issues

Downstream drugging improves RAS inhibition

Immune cell interaction key to better dengue vaccines

FDA accepts IND application for MT-8633

New zebrafish model allows screening for treatments for acute hyperuricemia

AGS signs research agreement with NIAID for experimental HIV/AIDS cell and gene therapy

PNP Therapeutics initiates phase I/II study of Ad/PNP-F-araAMP in local head and neck cancer

Bridge Biotherapeutics recruiting participants in first-in-human study of BBT-877

Huntingtin implicated in fragile X syndrome

Massachusetts Institute of Technology patents new AR antagonists

Lundbeck presents compounds for schizophrenia

Patient enrollment is ongoing in Akros Pharma's phase II study of JTE-451

Crinetics Pharmaceuticals discloses new somatostatin SST2 receptor agonists

Italian researchers synthesize new molecules targeting KCNH2 and ITGB1

Dual complement inhibition by CRIg/FH shows renoprotective effect in ischemia reperfusion injury

Codiak Biosciences describes new nanovesicles for inflammation-related conditions

NAPE-PLD, key regulator of intestinal fat absorption, liver lipid deposition and energy homeostasis

Innovent and Chipscreen collaborate to study chidamide, sintilimab and IBI-305 in colorectal cancer

Grant to support phase II development of AKL's APPA for osteoarthritis

First patient-derived xenograft models of primary central nervous system lymphomas

Docking library to include over 1 billion lead-like compounds for drug discovery

Biofabri initiates phase IIa study of TB vaccine candidate MTBVAC in South African neonates

Bionomics reports pharmacometric analysis of phase II RESTORE trial of BNC-210 for PTSD

Amgen begins first-in-human study of BiTE antibody AMG-160 in metastatic CRPC

New loci identified for type 2 diabetes in Japanese individuals

GlaxoSmithKline describes discovery of sulforaphane analogues for COPD

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...